Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

Lancet Infectious Diseases
Jul 2020 Volume 20 Number 7 p755-874, e148-e179
http://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial
Michelle J Groome, et al